|
House PDUFA Bill Would Cut FDA Response Time on Blocking Petitions for Biosimilars
The omnibus FDA user fee bill now before the House would limit to 150 days the amount of time the FDA has to respond to citizen petitions seeking to block biosimilars approvals.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives